Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30891615 | 1.00 | KIF11 (0.46) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL3871917 | 1.00 | KIF11 (0.46) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL447473 | 0.98 | KIF11 (0.48) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL7076981 | 0.93 | KIF11 (0.52) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL17817842 | 0.93 | KIF11 (0.52) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL7078537 | 0.93 | KIF11 (0.52) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL8176042 | 0.91 | KIF11 (0.50) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL7080175 | 0.91 | KIF11 (0.54) | KIF11ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL673282 | 0.88 | LMNA (0.43) | LMNA | |
| SCHEMBL7072713 | 0.85 | KIF11 (0.54) | KIF11ALDH1A1TDP1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118001928-A | Preparation method of integral all-hydrophobic polyvinylidene fluoride membrane for membrane distillation | 宁波大学 | 2024-05-10 | — | — | CN | claimed |
| EP-3745505-B1 | FUNCTIONALIZED LITHIUM ANODE FOR BATTERIES | ACONDICIONAMIENTO TARRASENSE (ES) | 2023-11-29 | — | — | EP | claimed |
| CN-117050031-A | Fluoro-thiazolidinone and its synthesis process | 扬州大学 | 2023-11-14 | — | — | CN | claimed |
| US-20220231283-A1 | FUNCTIONALIZED LITHIUM ANODE FOR BATTERIES | ACONDICIONAMIENTO TARRASENSE (ES) | 2022-07-21 | — | — | US | claimed |
| CN-114730865-A | Functionalized lithium-based anodes for batteries | 塔拉森斯调节公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114470296-A | Stable and super-strong antibacterial super-blood-dredging dressing and preparation method thereof | 珠海钛丰生物科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| WO-2020240308-A1 | FUNCTIONALIZED LITHIUM ANODE FOR BATTERIES | ACONDICIONAMIENTO TARRASENSE (ES) | 2020-12-03 | — | — | WO | claimed |
| EP-3745505-A1 | FUNCTIONALIZED LITHIUM ANODE FOR BATTERIES | Acondicionamiento Tarrasense (ES) | 2020-12-02 | — | — | EP | claimed |
| WO-2009082833-A1 | FUNCTIONAL FLUORIDE ANTI-BLEED AGENTS WITH REACTIVE GROUPS AN APPLICATION IN ORGANIC BASED CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2009-07-09 | — | — | WO | claimed |
| EP-4707386-A1 | ARTIFICIAL VIRUS CAPSID | AGC INC. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260049107-A1 | ARTIFICIAL VIRAL CAPSID | AGC Inc. (JP) | 2026-02-19 | — | — | US | disclosed |
| CN-119082663-A | Inert carbon fiber felt coating carrier and preparation method and application thereof | 湖南天氟新材料有限公司 | 2024-12-06 | — | — | CN | disclosed |
| WO-2024228371-A1 | ARTIFICIAL VIRUS CAPSID | ＡＧＣ株式会社 | 2024-11-07 | — | — | WO | disclosed |
| US-20240287131-A1 | PEPTIDE | AGC Inc. (JP) | 2024-08-29 | — | — | US | disclosed |
| WO-2009023402-A2 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | ACEA BIOSCIENCES INC. (US) | 2009-02-19 | — | — | WO | disclosed |
| US-20090048271-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | ACEA Therapeutics, Inc. | 2009-02-19 | — | — | US | disclosed |
| EP-1446432-B1 | COPOLYMERS CONTAINING FLUORINE, METHOD FOR THE PRODUCTION AND USE THEREOF | HENKEL KGAA (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-20040242822-A1 | Copolymers containing fluorine, method for the production and use thereof | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-02 | — | — | US | disclosed |
| EP-1446432-A2 | COPOLYMERS CONTAINING FLUORINE, METHOD FOR THE PRODUCTION AND USE THEREOF | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-08-18 | — | — | EP | disclosed |
| WO-2003033557-A2 | COPOLYMERS CONTAINING FLUORINE, METHOD FOR THE PRODUCTION AND USE THEREOF | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048271-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | MKI67, CCNC, HCCS | KIF11 2119/4885ALDH1A1 961/4885TDP1 2861/4885 |
| US-20240287131-A1 | PEPTIDE | SSTR5, SSTR4, NGLY1 | KIF11 2092/4885ALDH1A1 4248/4885TDP1 3990/4885 |
| US-20260049107-A1 | ARTIFICIAL VIRAL CAPSID | ZC3HAV1L, ZFR, SLC39A11 | KIF11 478/4885ALDH1A1 4225/4885TDP1 3236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.